Background/Aim: Non-melanoma skin cancer is the most common cancer in the world. Somatic mutations in the TP53 gene are associated with the development of this cancer. To describe mutations in exons 5-8 of the TP53 gene in a sample of Colombian patients with non-melanoma skin cancer. Materials and Methods: One hundred and fifteen patients with non-melanoma skin cancer were included. Exons 5-8 were amplified and analyzed by PCR-High Resolution Melting and Sanger sequencing. Results: Fifty-seven patients with basal cell carcinomas and 58 with squamous cell carcinomas were studied. 16% of patients with basal cell carcinoma and 26% of patients with squamous cell carcinoma had mutations in the TP53 gene. The most frequent mutations were substitutions, while three patients had deletions. The most frequent mutation was p.R158G. Conclusion: The analysis showed that Colombian individuals with non-melanoma skin cancer have genetic TP53 variants different from those reported as recurrent for this disease. Copyright 2022, International Institute of Anticancer Research.
Background/Aim: Non-melanoma skin cancer is the most common cancer in the world. Somatic mutations in the TP53 gene are associated with the development of this cancer. To describe mutations in exons 5-8 of the TP53 gene in a sample of Colombian patients with non-melanoma skin cancer. Materials and Methods: One hundred and fifteen patients with non-melanoma skin cancer were included. Exons 5-8 were amplified and analyzed by PCR-High Resolution Melting and Sanger sequencing. Results: Fifty-seven patients with basal cell carcinomas and 58 with squamous cell carcinomas were studied. 16% of patients with basal cell carcinoma and 26% of patients with squamous cell carcinoma had mutations in the TP53 gene. The most frequent mutations were substitutions, while three patients had deletions. The most frequent mutation was p.R158G. Conclusion: The analysis showed that Colombian individuals with non-melanoma skin cancer have genetic TP53 variants different from those reported as recurrent for this disease. Copyright 2022, International Institute of Anticancer Research.
Entities:
Keywords:
Mutations; TP53; melanoma; non-melanoma; skin cancer
Authors: Mary K Montes de Oca; Ross L Pearlman; Sarah F McClees; Rebecca Strickland; Farrukh Afaq Journal: Photochem Photobiol Date: 2017-03-14 Impact factor: 3.421
Authors: Reynaldo José Sant Anna Pereira de Souza; Adriana Prest Mattedi; Marcelo Lacerda Rezende; Marcelo de Paula Corrêa; Etiene Marques Duarte Journal: An Bras Dermatol Date: 2009-07 Impact factor: 1.896
Authors: Gillian Mitchell; Mandy L Ballinger; Stephen Wong; Chelsee Hewitt; Paul James; Mary-Anne Young; Arcadi Cipponi; Tiffany Pang; David L Goode; Alex Dobrovic; David M Thomas Journal: PLoS One Date: 2013-07-22 Impact factor: 3.240